Unravelling the role of mitochondrial dysfunction in the switching towards progressive MASLD by exploiting an AMLN diet-fed mouse model

E. Paolini,M. Meroni,M. Longo,M. Battistin,M. Ripolone,L. Napoli,S. Gatti,P. Dongiovanni

DOI: https://doi.org/10.1016/j.dld.2024.01.099

IF: 5.165

2024-02-01

Digestive and Liver Disease

Abstract:Background Mitochondrial maladaptation is a key event in the transition from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) to Steatohepatitis (MASH) up to fibrosis/cirrhosis. However, it remains to be defined how mitochondrial alterations evolve as the disease progresses. Aims We exploited a mice model fed high fat-high fructose diet (Amylin liver NASH (AMLN) diet) that resemble human MASLD to investigate the role of mitochondrial dysfunction in boosting severe disease. Method C57Bl/6 male mice were fed AMLN or standard diet for 14-22-28 weeks (Taconic-Biosciences), to feature simple steatosis, MASH, and fibrosis, respectively. Mitochondrial morphology and activity were assessed by TEM and Seahorse assays, respectively whereas mitobiogenesis and OXPHOS complexes by Western Blot. Results Mice fed AMLN diet recapitulated the human MASLD spectrum encompassing hepatic fat accumulation with a mixed micro/macro pattern, inflammation, and collagen deposition. TEM showed progressive morphologic dysfunction of mitochondria which appeared normo-shaped with rare misshapen ones in AMLN-steatosis and completely swollen in AMLN-MASH. In the fibrosis group we observed aberrant organelles with disorganized cristae and matrix loss. Mitochondrial derangement was paralleled by progressive fragmentation of endoplasmic reticulum, apoptotic nuclei and autophagic bodies. The mitophagy pathway was reduced in AMLN model and particularly in AMLN-fibrosis thus explaining the accumulation of damaged mitochondria. Furthermore, the citrate synthase and mitochondrial complexes activities alongside OXPHOS protein levels and ATP production were lowered across the disease, especially in the presence of MASH-fibrosis. The failed activity was paralleled by oxidative stress, lactate production and release of cell-free circulating mitochondrial-DNA, which reflects hepatic mitochondrial impairment. Consistently, the Seahorse assay showed a progressive reduction of oxygen consumption rate in primary hepatocytes isolated from mice fed AMLN diet. Conclusion By exploiting the AMLN mice model, we demonstrated that alterations in mitochondrial morphology, lifecycle and activity feature all disease stages, thus fostering the switching to MASH and fibrosis.

gastroenterology & hepatology